ZA201207199B - Immune therapy - Google Patents
Immune therapyInfo
- Publication number
- ZA201207199B ZA201207199B ZA2012/07199A ZA201207199A ZA201207199B ZA 201207199 B ZA201207199 B ZA 201207199B ZA 2012/07199 A ZA2012/07199 A ZA 2012/07199A ZA 201207199 A ZA201207199 A ZA 201207199A ZA 201207199 B ZA201207199 B ZA 201207199B
- Authority
- ZA
- South Africa
- Prior art keywords
- immune therapy
- immune
- therapy
- Prior art date
Links
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- C07K14/16—HIV-1 ; HIV-2
- C07K14/163—Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1004656.3A GB201004656D0 (en) | 2010-03-19 | 2010-03-19 | Immune therapy |
PCT/EP2011/001606 WO2011113618A1 (en) | 2010-03-19 | 2011-03-21 | Immune therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201207199B true ZA201207199B (en) | 2013-05-29 |
Family
ID=42228031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/07199A ZA201207199B (en) | 2010-03-19 | 2012-09-26 | Immune therapy |
Country Status (5)
Country | Link |
---|---|
US (1) | US9630995B2 (en) |
EP (1) | EP2547697B1 (en) |
GB (1) | GB201004656D0 (en) |
WO (1) | WO2011113618A1 (en) |
ZA (1) | ZA201207199B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170044218A1 (en) | 2014-04-24 | 2017-02-16 | Janssen Sciences Ireland Uc | Use of a HIV derived accessory protein for the reactivation of latent HIV |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6024965A (en) | 1996-10-18 | 2000-02-15 | Erasums University Rotterdam | Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection |
GB0323840D0 (en) | 2003-10-10 | 2003-11-12 | Ist Superiore Sanita | Vaccines |
GB0405480D0 (en) | 2004-03-11 | 2004-04-21 | Istituto Superiore Di Sanito | Novel tat complexes,and vaccines comprising them |
US20090142319A1 (en) | 2007-11-30 | 2009-06-04 | Therakos, Inc. | METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST |
-
2010
- 2010-03-19 GB GBGB1004656.3A patent/GB201004656D0/en not_active Ceased
-
2011
- 2011-03-21 US US13/636,118 patent/US9630995B2/en active Active
- 2011-03-21 WO PCT/EP2011/001606 patent/WO2011113618A1/en active Application Filing
- 2011-03-21 EP EP11714488.1A patent/EP2547697B1/en active Active
-
2012
- 2012-09-26 ZA ZA2012/07199A patent/ZA201207199B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2547697B1 (en) | 2018-01-03 |
WO2011113618A1 (en) | 2011-09-22 |
EP2547697A1 (en) | 2013-01-23 |
WO2011113618A4 (en) | 2011-11-24 |
GB201004656D0 (en) | 2010-05-05 |
US20130058973A1 (en) | 2013-03-07 |
US9630995B2 (en) | 2017-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1800042I1 (en) | Antiviral therapy | |
IL222481A0 (en) | Combination therapy | |
EP2552323A4 (en) | Combination therapy | |
ZA201305897B (en) | Combination therapy | |
PL2652193T3 (en) | Treatment | |
ZA201400120B (en) | Combination therapy | |
ZA201300967B (en) | Combination anti-cancer therapy | |
EP2701744A4 (en) | Combination therapy | |
GB201013573D0 (en) | Treatment | |
EP2595594A4 (en) | Massager | |
GB201005394D0 (en) | Therapy | |
GB201016864D0 (en) | Therapeutic methods | |
ZA201207199B (en) | Immune therapy | |
EP2629766A4 (en) | Combination therapy | |
GB201014097D0 (en) | Treatment | |
GB201004674D0 (en) | Novel therapy | |
GB201114226D0 (en) | Combination therapy | |
GB201120096D0 (en) | Novel therapy | |
GB201018496D0 (en) | Oro-tracheal defibrillator | |
GB201021319D0 (en) | Treatment | |
GB201021708D0 (en) | Novel Therapeutic use |